JP2023519189A5 - - Google Patents

Info

Publication number
JP2023519189A5
JP2023519189A5 JP2022556000A JP2022556000A JP2023519189A5 JP 2023519189 A5 JP2023519189 A5 JP 2023519189A5 JP 2022556000 A JP2022556000 A JP 2022556000A JP 2022556000 A JP2022556000 A JP 2022556000A JP 2023519189 A5 JP2023519189 A5 JP 2023519189A5
Authority
JP
Japan
Prior art keywords
extract
weight
ginsenosides
composition
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556000A
Other languages
English (en)
Japanese (ja)
Other versions
JP7850670B2 (ja
JP2023519189A (ja
Filing date
Publication date
Priority claimed from GBGB2004121.6A external-priority patent/GB202004121D0/en
Priority claimed from GBGB2005288.2A external-priority patent/GB202005288D0/en
Application filed filed Critical
Priority claimed from PCT/EP2021/056788 external-priority patent/WO2021185890A1/en
Publication of JP2023519189A publication Critical patent/JP2023519189A/ja
Publication of JP2023519189A5 publication Critical patent/JP2023519189A5/ja
Application granted granted Critical
Publication of JP7850670B2 publication Critical patent/JP7850670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556000A 2020-03-20 2021-03-17 ギンセノシド組成物 Active JP7850670B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2004121.6A GB202004121D0 (en) 2020-03-20 2020-03-20 Improved compositions
GB2004121.6 2020-03-20
GB2005288.2 2020-04-09
GBGB2005288.2A GB202005288D0 (en) 2020-04-09 2020-04-09 Improved compositions
PCT/EP2021/056788 WO2021185890A1 (en) 2020-03-20 2021-03-17 Ginsenoside compositions

Publications (3)

Publication Number Publication Date
JP2023519189A JP2023519189A (ja) 2023-05-10
JP2023519189A5 true JP2023519189A5 (cg-RX-API-DMAC7.html) 2024-03-27
JP7850670B2 JP7850670B2 (ja) 2026-04-23

Family

ID=75108332

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022555990A Active JP7808042B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物
JP2022556000A Active JP7850670B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022555990A Active JP7808042B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物

Country Status (8)

Country Link
US (2) US20230124503A1 (cg-RX-API-DMAC7.html)
EP (2) EP4121061A1 (cg-RX-API-DMAC7.html)
JP (2) JP7808042B2 (cg-RX-API-DMAC7.html)
CN (2) CN115315264A (cg-RX-API-DMAC7.html)
AU (2) AU2021238639B2 (cg-RX-API-DMAC7.html)
BR (2) BR112022015826A2 (cg-RX-API-DMAC7.html)
CA (2) CA3174699A1 (cg-RX-API-DMAC7.html)
WO (2) WO2021185897A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230124503A1 (en) * 2020-03-20 2023-04-20 Givaudan Sa Ginsenoside compositions
JP2023161983A (ja) * 2022-04-26 2023-11-08 石川県公立大学法人 サポニンを含む酪酸産生菌増殖能向上組成物、腸内常在菌増殖能向上組成物、乳酸菌増殖能向上組成物及びビフィズス菌増殖能向上組成物
CN117224553B (zh) * 2023-11-02 2025-08-12 浙江大学 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用
CN117752706B (zh) * 2023-12-20 2025-10-14 浙江天皇药业有限公司 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用
WO2025261873A1 (en) 2024-06-20 2025-12-26 Givaudan Sa Improvements in or relating to compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US9956241B2 (en) * 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
KR102200012B1 (ko) * 2013-04-02 2021-01-08 (주)아모레퍼시픽 인삼열매 추출물을 포함하는 뇌 활성화 조성물
US10456436B2 (en) * 2013-11-04 2019-10-29 Wen Luan Wendy Hsiao Use of herbal saponins to regulate gut microflora
BR112020000963A2 (pt) 2017-07-18 2020-07-14 Senescence Life Sciences Pte. Ltd. composições e métodos para o tratamento e prevenção de declínio cognitivo e conservação da função neuronal
CN110613802A (zh) * 2018-06-20 2019-12-27 珠海岐微生物科技有限公司 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途
CN109432304A (zh) * 2018-12-03 2019-03-08 杭州胡庆余堂药业有限公司 一种含铁皮石斛组合物在药物制备中的应用
US20230124503A1 (en) 2020-03-20 2023-04-20 Givaudan Sa Ginsenoside compositions

Similar Documents

Publication Publication Date Title
JP2020527583A5 (cg-RX-API-DMAC7.html)
JP5979931B2 (ja) 医薬組成物
JP2023518064A5 (cg-RX-API-DMAC7.html)
US20220387455A1 (en) Treatment of moderate to severe influenza
JP2024531799A5 (cg-RX-API-DMAC7.html)
WO2019114686A1 (en) Composition for teeating dementia and preparation method and use thereof
JP2024522163A5 (cg-RX-API-DMAC7.html)
JP3114017B1 (ja) 鎮痛健康補助食品
JP2022019937A (ja) ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物
JPWO2014010658A1 (ja) ヒハツ配合製剤
WO2017101696A1 (zh) 治疗急慢性呼吸困难的西药组合物及其制备方法
JP2001122795A (ja) 感染性疾患予防・治療剤
CN110882245A (zh) 一种改善睡眠的组合物及其用途
CN117159679A (zh) 一种治疗流感的中药组合物及其制备方法和应用
CN104286855A (zh) 一种牛樟芝保健品及其用途
JPS6393722A (ja) 医薬の処方
CN108066651B (zh) 一种用于治疗抗抑郁药所致盗汗的健脾养阴中药组合物
CN115835862A (zh) 治疗阿尔茨海默病的组合及其应用
CN112057559A (zh) 霍山石斛提取物在预防、缓解和/或治疗尿酸性肾病药物中的应用
US12622942B2 (en) Method for treating coronavirus infectious disease and complicated severe coma, ultra-low blood oxygen, moribund disease thereof
JP2006508993A5 (cg-RX-API-DMAC7.html)
CN103877554A (zh) 一种治疗心脏病的药物组合物及其制备方法和用途
Mahler Pro: Inhaled corticosteroids for chronic obstructive pulmonary disease
JP5963791B2 (ja) 月経前症候群に付随する症状及び月経前不快気分障害を緩和するのに使用される組成物
CN101579369B (zh) 一种治疗佝偻病的药物组合物及其制备方法